Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Unraveling the enigma of salty taste detection

  • Tiny worm opens big discovery on nerve degeneration

  • Mobile communication keeps couples who live close to one another even closer

  • Scientists learn how young brains form lifelong memories by studying worms' food choices

  • Memory replay prioritizes high-reward memories

  • Starfish reveal the origins of brain messenger molecules

  • Alcohol-impaired driving crimes spike immediately after drinking age

  • Blocking stress protein relieves chronic pain in mice

  • Why you may skimp on your Valentine's Day gift

  • Daters move toward (or away from) marriage in four different ways: Where do you fit?

  •